世界の皮膚がん診断＆治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Skin Cancer Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5270 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、皮膚がん診断＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（基底細胞がん、扁平上皮がん、黒色腫）、用途別市場規模（病院、診療所、がん研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚がん診断＆治療の市場動向 ・企業の競争状況、市場シェア ・皮膚がん診断＆治療の種類別市場規模（基底細胞がん、扁平上皮がん、黒色腫） ・皮膚がん診断＆治療の用途別市場規模（病院、診療所、がん研究センター、その他） ・皮膚がん診断＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚がん診断＆治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚がん診断＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚がん診断＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚がん診断＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Merck、Novartis、Pfizer、Qiagen、Roche、Sanofi、Abbott、AstraZeneca、Bristol-Myers Squibb、Eli Lilly） ・結論

On the basis of the type of tissue affected, there are three major types of skin cancer, namely, basal cell carcinoma, squamous-cell carcinoma, and melanoma. Factors such as increasing incidences of skin cancer, favorable government initiatives, the development of novel immunotherapies, and the extension of current therapies are fueling the growth of the market. However, high cost associated with therapy, a stringent regulatory environment, and the lack of awareness in the general population could adversely affect market growth.
In 2017, North America was the largest regional market, in terms of revenue. The high prevalence of skin cancer and its risk factors, a favorable reimbursement environment, and high adoption rate of novel technologies are primary factors behind the large market size. The Asia-Pacific region is expected to grow at a rapid pace over the forecast period, owing to increasing healthcare expenditure and government initiatives aimed at increasing awareness in the developing economies of the region.

Market Analysis and Insights: Global Skin Cancer Diagnostics and Therapeutics Market
The global Skin Cancer Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Cancer Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Cancer Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Cancer Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Cancer Diagnostics and Therapeutics market.

Global Skin Cancer Diagnostics and Therapeutics Scope and Market Size
Skin Cancer Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Cancer Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Basal Cell Carcinoma
Squamous Cell Carcinoma
Melanoma

Segment by Application
Hospital
Clinic
Cancer Research Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi
Abbott
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Basal Cell Carcinoma
1.2.3 Squamous Cell Carcinoma
1.2.4 Melanoma
1.3 Market by Application
1.3.1 Global Skin Cancer Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Cancer Research Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Skin Cancer Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Skin Cancer Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Skin Cancer Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Cancer Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Skin Cancer Diagnostics and Therapeutics Industry Dynamic
2.3.1 Skin Cancer Diagnostics and Therapeutics Market Trends
2.3.2 Skin Cancer Diagnostics and Therapeutics Market Drivers
2.3.3 Skin Cancer Diagnostics and Therapeutics Market Challenges
2.3.4 Skin Cancer Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Skin Cancer Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Skin Cancer Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Cancer Diagnostics and Therapeutics Revenue
3.4 Global Skin Cancer Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Skin Cancer Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Diagnostics and Therapeutics Revenue in 2020
3.5 Skin Cancer Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Skin Cancer Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Skin Cancer Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Skin Cancer Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Skin Cancer Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Skin Cancer Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Skin Cancer Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Skin Cancer Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Skin Cancer Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Skin Cancer Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Skin Cancer Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Skin Cancer Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Skin Cancer Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Skin Cancer Diagnostics and Therapeutics Introduction
11.2.4 Merck Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Skin Cancer Diagnostics and Therapeutics Introduction
11.3.4 Novartis Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Skin Cancer Diagnostics and Therapeutics Introduction
11.4.4 Pfizer Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Details
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Skin Cancer Diagnostics and Therapeutics Introduction
11.5.4 Qiagen Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Qiagen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Skin Cancer Diagnostics and Therapeutics Introduction
11.6.4 Roche Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Skin Cancer Diagnostics and Therapeutics Introduction
11.7.4 Sanofi Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Skin Cancer Diagnostics and Therapeutics Introduction
11.8.4 Abbott Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Skin Cancer Diagnostics and Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Introduction
11.10.4 Bristol-Myers Squibb Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Skin Cancer Diagnostics and Therapeutics Introduction
11.11.4 Eli Lilly Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
11.11.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Skin Cancer Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Basal Cell Carcinoma
Table 3. Key Players of Squamous Cell Carcinoma
Table 4. Key Players of Melanoma
Table 5. Global Skin Cancer Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Skin Cancer Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Skin Cancer Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Skin Cancer Diagnostics and Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Skin Cancer Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Table 11. Skin Cancer Diagnostics and Therapeutics Market Trends
Table 12. Skin Cancer Diagnostics and Therapeutics Market Drivers
Table 13. Skin Cancer Diagnostics and Therapeutics Market Challenges
Table 14. Skin Cancer Diagnostics and Therapeutics Market Restraints
Table 15. Global Skin Cancer Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Skin Cancer Diagnostics and Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Skin Cancer Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnostics and Therapeutics as of 2020)
Table 18. Ranking of Global Top Skin Cancer Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Skin Cancer Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Skin Cancer Diagnostics and Therapeutics Product Solution and Service
Table 22. Date of Enter into Skin Cancer Diagnostics and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Skin Cancer Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Skin Cancer Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Skin Cancer Diagnostics and Therapeutics Product
Table 65. GlaxoSmithKline Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Skin Cancer Diagnostics and Therapeutics Product
Table 70. Merck Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Skin Cancer Diagnostics and Therapeutics Product
Table 75. Novartis Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Skin Cancer Diagnostics and Therapeutics Product
Table 80. Pfizer Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Qiagen Company Details
Table 83. Qiagen Business Overview
Table 84. Qiagen Skin Cancer Diagnostics and Therapeutics Product
Table 85. Qiagen Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Qiagen Recent Development
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Skin Cancer Diagnostics and Therapeutics Product
Table 90. Roche Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Roche Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Skin Cancer Diagnostics and Therapeutics Product
Table 95. Sanofi Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Abbott Company Details
Table 98. Abbott Business Overview
Table 99. Abbott Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Abbott Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Skin Cancer Diagnostics and Therapeutics Product
Table 104. AstraZeneca Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Skin Cancer Diagnostics and Therapeutics Product
Table 109. Bristol-Myers Squibb Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Eli Lilly Company Details
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Skin Cancer Diagnostics and Therapeutics Product
Table 114. Eli Lilly Revenue in Skin Cancer Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Eli Lilly Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Skin Cancer Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Basal Cell Carcinoma Features
Figure 3. Squamous Cell Carcinoma Features
Figure 4. Melanoma Features
Figure 5. Global Skin Cancer Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Cancer Research Center Case Studies
Figure 9. Others Case Studies
Figure 10. Skin Cancer Diagnostics and Therapeutics Report Years Considered
Figure 11. Global Skin Cancer Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Skin Cancer Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Skin Cancer Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Skin Cancer Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Skin Cancer Diagnostics and Therapeutics Market Share by Players in 2020
Figure 16. Global Top Skin Cancer Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Cancer Diagnostics and Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Skin Cancer Diagnostics and Therapeutics Revenue in 2020
Figure 18. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Skin Cancer Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Skin Cancer Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Skin Cancer Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Skin Cancer Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Skin Cancer Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Skin Cancer Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Skin Cancer Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Skin Cancer Diagnostics and Therapeutics Market Share by Region (2016-2027)
Figure 40. China Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Skin Cancer Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Skin Cancer Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Skin Cancer Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Skin Cancer Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Skin Cancer Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 63. Qiagen Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Skin Cancer Diagnostics and Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---